Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells

CD19-directed CAR-T-cells (CD19-CAR) have demonstrated remarkable clinical results in patients suffering from refractory or relapsed lymphoma and acute lymphoblastic leukemia. In order to further optimize follow-up, to explain treatment failure, and to control adverse events biomarkers for monitorin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Mol Biosci
Autors principals: Mika, Thomas, Maghnouj, Abdelouahid, Klein-Scory, Susanne, Ladigan-Badura, Swetlana, Baraniskin, Alexander, Thomson, Julia, Hasenkamp, Justin, Hahn, Stephan A., Wulf, Gerald, Schroers, Roland
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Molecular Biosciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243121/
https://ncbi.nlm.nih.gov/pubmed/32500079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.00084
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars